Nesiritide Usage in Decompensated Heart Failure: Cost Effectiveness and Clinical Effectiveness

Publisher： Karger

E-ISSN： 1424-0556|5|2|81-88

ISSN： 1422-9528

Source： Heart Drug, Vol.5, Iss.2, 2005-03, pp. : 81-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on nesiritide for treatment of decompensated heart failure

By Hobbs R.E. Mills R.M. Young J.B.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 935-942

Informa Healthcare

Access to resources Recommend Favorite

Benefit-Risk Assessment of Nesiritide in the Treatment of Acute Decompensated Heart Failure

By Yancy Clyde W.

Drug Safety, Vol. 30, Iss. 9, 2007-01 ,pp. : 765-781

Adis International

Access to resources Recommend Favorite

Nesiritide: A Review of its Use in Acute Decompensated Heart Failure

By Keating G.M. Goa K.L.

Drugs, Vol. 63, Iss. 1, 2003-01 ,pp. : 47-70

Adis International

Access to resources Recommend Favorite

Nesiritide: A Promising New Drug for the Treatment of Decompensated Heart Failure

Heart Drug, Vol. 2, Iss. 1, 2002-04 ,pp. : 39-46

Karger

Access to resources Recommend Favorite

Cost Effectiveness of Biventricular Pacemakers in Heart Failure Patients

By Heerey Adrienne

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 2, 2006-01 ,pp. : 129-137

Adis International

Access to resources Recommend Favorite